All ETFs

Watch Compare

MNTL

ETF

MNTL · UNKNOWN · 44 holdings

Quick Summary

Price History

Concentration Risk

53.10% Top-heavy

Low risk High risk

The top 10 holdings make up 53.10% of this ETF. A bad day for those few names drags the whole fund down with them.

Top Holdings Today

Weighted by position size

VRTX

▼ -1.36%

REGN

▼ -1.59%

ALNY

▼ -2.16%

ARGX

▲ 0.96%

TEVA

▼ -1.76%

NBIX

▲ 0.43%

LLY

▼ -2.39%

CRNX

▼ -0.98%

BIIB

▼ -0.20%

SYK

▼ -0.63%

Weighted avg. of top holdings ▼ -1.06%

Sector Allocation

Healthcare

88.26%

Financial Services

2.23%

Manufacturing

2.14%

Services

0.91%

Top 10 Holdings

53.10% of fund

VRTX Vertex Pharmaceuticals Inc

10.46%

REGN Regeneron Pharmaceuticals Inc

6.48%

ALNY Alnylam Pharmaceuticals Inc

6.22%

ARGX Argenx SE

5.25%

TEVA Teva Pharmaceutical Industries

4.99%

NBIX Neurocrine Biosciences Inc

4.95%

LLY Eli Lilly & Co

4.16%

CRNX Crinetics Pharmaceuticals Inc

4.11%

BIIB Biogen Inc

3.34%

SYK Stryker Corp

3.14%

Other positions

2.42%

All Holdings (44)

Top 10: 53.10% of fund

#	Ticker	Name	Weight	Shares	Market Value
1	VRTX	Vertex Pharmaceuticals Inc	10.46%	2,298	1.02 M
2	REGN	Regeneron Pharmaceuticals Inc	6.48%	1,284	629,519.52
3	ALNY	Alnylam Pharmaceuticals Inc	6.22%	1,982	603,637.92
4	ARGX	Argenx SE	5.25%	890	510,201.4
5	TEVA	Teva Pharmaceutical Industries	4.99%	28,861	484,287.58
6	NBIX	Neurocrine Biosciences Inc	4.95%	3,904	480,270.08
7	LLY	Eli Lilly & Co	4.16%	547	403,505.49
8	CRNX	Crinetics Pharmaceuticals Inc	4.11%	13,066	398,643.66
9	BIIB	Biogen Inc	3.34%	2,501	324,604.79
10	SYK	Stryker Corp	3.14%	798	305,346.72
11	CPRX	Catalyst Pharmaceuticals Inc	2.92%	11,352	283,345.92
12	IONS	Ionis Pharmaceuticals Inc	2.87%	8,318	278,736.18
13	MDT	Medtronic PLC	2.54%	2,976	246,948.48
14	AXSM	Axsome Therapeutics Inc	2.52%	2,327	244,707.32
15	ACAD	ACADIA Pharmaceuticals Inc	2.35%	10,596	228,555.72
16	UCB	UCB SA	2.23%	1,193	216,598.77
17	DNLI	Denali Therapeutics Inc	2.07%	15,174	200,903.76
18	DXCM	Dexcom Inc	1.97%	2,231	191,419.8
19	ALKS	Alkermes PLC	1.87%	5,940	181,823.4
20	JAZZ	Jazz Pharmaceuticals PLC	1.86%	1,672	180,693.04
21	XENE	Xenon Pharmaceuticals Inc	1.82%	6,111	176,302.35
22	RNA	Avidity Biosciences Inc	1.72%	5,392	167,044.16
23	PEN	Penumbra Inc	1.70%	617	164,720.49
24	OPCH	Option Care Health Inc	1.67%	4,975	162,583.0
25	PTCT	PTC Therapeutics Inc	1.56%	3,124	151,576.48
26	SRRK	Scholar Rock Holding Corp	1.44%	4,836	140,292.36
27	SHL	Siemens Healthineers AG	1.36%	2,495	131,958.42
28	6869	Sysmex Corp	1.06%	6,108	103,253.83
29	ORNBV	Orion Oyj	1.01%	1,440	97,693.91
30	TALK	Talkspace Inc	0.91%	27,834	88,790.46
31	IMVT	Immunovant Inc	0.90%	5,866	87,110.1
32	SRPT	Sarepta Therapeutics Inc	0.75%	1,943	73,056.8
33	DAWN	Day One Biopharmaceuticals Inc	0.74%	11,305	72,125.9
34	ACHC	Acadia Healthcare Co Inc	0.61%	2,596	58,773.44
35	4523	Eisai Co Ltd	0.60%	2,036	58,591.86
36	BHVN	Biohaven Ltd	0.58%	3,831	56,737.11
37	DYN	Dyne Therapeutics Inc	0.58%	4,717	56,415.32
38	NTLA	Intellia Therapeutics Inc	0.54%	7,677	52,740.99
39	VYGR	Voyager Therapeutics Inc	0.42%	14,960	40,990.4
40	PRAX	Praxis Precision Medicines Inc	0.42%	1,055	40,670.25
41	PRTA	Prothena Corp PLC	0.30%	6,351	29,151.09
42	SLDB	Solid Biosciences Inc	0.29%	8,649	27,763.29
43	ARVN	Arvinas Inc	0.15%	2,074	14,932.8
44	RAPP	Rapport Therapeutics Inc	0.13%	1,499	12,396.73

Showing top 10 of 44 holdings · Listed: 97.58% · 2.42% in other positions

Related ETFs

QAAHBX

QAAGZX

KOKU

Xtrackers MSCI Kokusai Equity ETF

0.00%

ACWI

iShares MSCI ACWI ETF

▲ 0.13%

VHT

Vanguard Health Care ETF

▼ -0.98%

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

Growth

Rev 5Y: N/A · Earnings 1Y: N/A

Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A

Profitability

ROE: N/A · Net Margin: N/A

Revenue (TTM)	N/A	Net Income (TTM)	N/A
ROE	N/A	ROA	N/A
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	N/A
ROIC	N/A	FCF Growth (3Y)	N/A

Safety

D/E: N/A · Current: N/A

Debt / Equity	N/A	Current Ratio	N/A
Interest Coverage	N/A	Asset Turnover	N/A
Working Capital	N/A	Tangible Book Value	N/A

Dividends

Yield: N/A · Payout: N/A

Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A

Valuation

P/E: N/A · EV/EBITDA: N/A

P/E Ratio	N/A	Forward P/E	N/A
P/B Ratio	N/A	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	N/A
Market Cap	N/A	Enterprise Value	N/A